Clordisys Solutions
- Company typePrivate
- Founded2001
- HeadquartersSomerville, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Clordisys Solutions firmographics
Firmographics- Name
- Clordisys Solutions
- Legal name
- ClorDiSys Solutions, LLC
- Website
- https://clordisys.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Clordisys Solutions industry classification
Industry- Product category
- Contract Sterilization Services
- akta.pro primary industry
- Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)
Keywords
Where Clordisys Solutions is headquartered
LocationHeadquarters
- HQ city
- Somerville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Clordisys Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Sterilization Services: FDA-registered, ISO 13485-certified contract sterilization facility providing chlorine dioxide gas sterilization for medical devices, pharmaceuticals, and combination products. Services include initial assessment and consultation, production processing with real-time monitoring and batch records, regulatory support for FDA submissions and international pathways, and certificates of sterilization for every processed lot. Same-day processing available with 24/7 capabilities.
- EO to CD Conversion Consulting: Conversion services helping customers transition from ethylene oxide to chlorine dioxide, leveraging existing infrastructure while upgrading to superior CD technology through proprietary conversion methods
- Material Compatibility Testing: Testing services evaluating material compatibility with chlorine dioxide gas under worst-case sterilization conditions including extended exposure times and elevated concentrations, evaluating physical, chemical, and functional properties to support FDA submissions
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Clordisys Solutions product offering
Product offeringCore offering
Clordisys Solutions provides FDA-registered, ISO 13485-certified contract sterilization services using its proprietary Pure CD (chlorine dioxide) gas technology for medical devices, pharmaceuticals, and combination products. The service delivers ambient temperature sterilization with no toxic residuals, same-day processing, and full regulatory pathway support. The company also offers EO to CD conversion services enabling facilities to transition from ethylene oxide to chlorine dioxide, plus material compatibility testing.
Product overview
Clordisys Solutions is a provider of chlorine dioxide gas contract sterilization services, built around its proprietary Pure CD Technology. The core offering is its FDA-registered, ISO 13485-certified contract sterilization facility, supplemented by EO to CD Conversion Services that allow facilities to transition from ethylene oxide. The company serves three primary industry segments: Medical Device Sterilization, Pharmaceutical Sterilization, and Combination Device Sterilization. The portfolio is unified by the Pure CD Technology platform, which provides ambient temperature, residue-free sterilization as an alternative to ethylene oxide, irradiation, and other gas sterilization methods.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Sterilization Services FDA-registered, ISO 13485-certified contract sterilization facility offering chlorine dioxide gas sterilization for complex medical devices, pharmaceuticals, and combination products with faster processing times and no toxic residuals. Services include initial assessment and consultation, production processing with real-time monitoring and batch records, regulatory support for FDA submissions, and certificates of sterilization for every processed lot. Same-day processing available with 24/7 capabilities.
- EO to CD Conversion Services Conversion services enabling facilities to leverage existing ethylene oxide infrastructure while upgrading to chlorine dioxide technology through a patented conversion system. Helps sterilization facilities transition from EO to CD with reduced capital investment.
- Material Compatibility Testing Testing services evaluating material compatibility with chlorine dioxide gas under worst-case sterilization conditions including extended exposure times and elevated concentrations, assessing physical, chemical, and functional properties to support FDA submissions.
- Medical Device Sterilization Specialized sterilization services for complex medical devices including surgical instruments, implants, electronic devices, and smart implants with embedded electronics that cannot withstand traditional sterilization methods such as heat, radiation, or ethylene oxide.
- Pharmaceutical Sterilization Contract sterilization services for active pharmaceutical ingredients, powders, crystalline materials, biologics, lyophilized excipients, prefilled syringes, autoinjectors, inhalation devices, transdermal delivery systems, implantable drug pumps, controlled-release systems, and other temperature-sensitive pharmaceutical compounds.
- Combination Device Sterilization Sterilization services for combination products such as drug-eluting implants, smart auto-injectors, cardiovascular stents with therapeutic coatings, orthopedic implants with antimicrobial surfaces, catheter systems with drug-delivery capabilities, insulin pens with electronic monitoring, and connected packaging with patient communication systems requiring preservation of both drug stability and device functionality.
Companies that use Clordisys Solutions
Customer profileSegments3 records
Ideal customer profiles3 records
Clordisys Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Clordisys Solutions partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights5 records
Clordisys Solutions competitors and assessment
Company assessmentDirect peers
- Sterigenics (Sotera Health): Largest global contract sterilization services provider (EO, gamma, E-beam) and the dominant incumbent Clordisys directly competes against. Both serve medical device and pharmaceutical manufacturers with validated sterilization under FDA/ISO frameworks.
- Noxilizer: Nitrogen dioxide (NO2) sterilization technology provider and the closest direct alternative-modality competitor to Clordisys' chlorine dioxide. Both target the same EO-alternative use cases for medical devices and pharma.
- Cosmed Group: Mid-sized contract sterilization services provider (EO, gamma, E-beam) serving medical device and pharmaceutical customers. Comparable business model and customer base to Clordisys, though focused on conventional modalities.
- E-BEAM Services: Contract electron beam sterilization services provider for medical devices, pharmaceuticals, and food. Competes with Clordisys for alternative-modality share but is limited to radiation-compatible products.
- Pacific Bio-Material Management: Contract sterilization services provider offering EO, gamma, and E-beam modalities to medical device manufacturers. Smaller-scale competitor with comparable service model and customer focus.
- Andersen Sterilizers: Provider of dry-heat and alternative sterilization equipment and contract services for medical devices and pharmaceuticals. Competes in the broader alternative-modality segment for customers seeking non-EO, non-radiation solutions.
Broad incumbents
- STERIS: Major sterilization services and equipment provider offering EO, gamma, and VHP modalities across a broad portfolio. Competes with Clordisys for contract sterilization work and has the scale to invest in alternative modalities if the EO transition accelerates.
- Getinge: Large medical device and sterilization equipment/services company with contract sterilization operations and a broad portfolio. Competes with Clordisys primarily as an incumbent with deeper installed base and capital resources.
Regional players
- Medistri: Swiss-headquartered contract sterilization and laboratory services provider serving European medical device and pharma customers. Similar EO and gamma service profile but geographically complementary rather than overlapping with Clordisys.
Others
- Allentown LLC: Clordisys' parent company since December 2023, providing complementary decontamination and sterilization equipment (caging, racks, washers) primarily for the research and vivarium segments. Parent owns Clordisys but the two serve distinct adjacent markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Clordisys Solutions social profiles
Digital presenceClordisys Solutions compliance and trust
Trust signalCompliance4 records
Clordisys Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clordisys Solutions leadership team
Management profileNumber of profiles
Profiles6 records
Clordisys Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clordisys Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clordisys Solutions
What does Clordisys Solutions do?
Clordisys Solutions provides FDA-registered, ISO 13485-certified contract sterilization services using its proprietary Pure CD (chlorine dioxide) gas technology for medical devices, pharmaceuticals, and combination products. The service delivers ambient temperature sterilization with no toxic residuals, same-day processing, and full regulatory pathway support. The company also offers EO to CD conversion services enabling facilities to transition from ethylene oxide to chlorine dioxide, plus material compatibility testing.
Is Clordisys Solutions a public or private company?
Clordisys Solutions is a private company. It is classified as corporate owned and is currently operating.
When was Clordisys Solutions founded?
Clordisys Solutions was founded in 2001. It employs 11 to 50 people.
Where is Clordisys Solutions based?
Clordisys Solutions is headquartered in Somerville, United States, in the North America region.
How does Clordisys Solutions make money?
Three revenue lines are on record. Contract Sterilization Services are the primary driver. The others are EO to CD Conversion Consulting and material Compatibility Testing.
Who are Clordisys Solutions's main competitors?
Direct peers on record are Sterigenics (Sotera Health), Noxilizer, Cosmed Group, E-BEAM Services, Pacific Bio-Material Management and Andersen Sterilizers. Broad incumbents are STERIS and Getinge. Medistri is listed as a regional player. Allentown LLC is listed as an others.
Does Clordisys Solutions have an API?
No public API is recorded for Clordisys Solutions.
What industry is Clordisys Solutions in?
Clordisys Solutions's product category is Contract Sterilization Services. Its primary akta.pro industry code is HLAHANAB, Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers).